New hope for newborns: seizure drug shows promise in brain injury

NCT ID NCT02229123

Completed Symptom relief Sponsor: University Hospital, Tours Source: ClinicalTrials.gov ↗

First seen Jan 08, 2026 · Last updated Jun 18, 2026 · Updated 27 times

Summary

This study tested the drug levetiracetam as a first treatment for seizures in 18 full-term newborns who had brain injury from lack of oxygen at birth. The goal was to find the right dose and check if the drug is safe and works well. The study measured how much seizures decreased on brain wave tests and watched for side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEONATAL SEIZURES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Néonatologie

Rennes, 35000, France
Service de Néonatologie

Tours, 37 000, France
Service de Pédiatrie néonatale et réanimation

Rouen, 76031, France
Service de réanimation et service néonatale

Orléans, 45100, France
Service de réanimation néonatale

Angers, 49000, France
Service de réanimation néonatale

Lille, 59037, France
Service de réanimation néonatale

Reims, 51092, France
Service de réanimation néonatale et pédiatrique

Paris, 75012, France

Conditions

The condition(s) this trial relates to.

brain hypoxia - ischemia perinatal asphyxia visual epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEONATAL SEIZURES